Australia

8 Vaccines Approved for Use in Australia

Protein Subunit

Novavax

Nuvaxovid

Approved in 40 countries
22 trials in 14 countries
Approval Source: health.gov.au
RNA

Moderna

Spikevax

Approved in 88 countries
70 trials in 24 countries
Approval Source: pm.gov.au
RNA

Pfizer/BioNTech

Comirnaty

Approved in 149 countries
100 trials in 31 countries
Approval Source: abc.net.au
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Approval Source: tga.gov.au
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 149 countries
73 trials in 34 countries
Approval Source: theguardian.com
RNA

Moderna

Spikevax Bivalent Original/Omicron BA.1

Approved in 38 countries
5 trials in 4 countries
Approval Source: 9news.com.au
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Jcovden

Approved in 113 countries
26 trials in 25 countries
Approval Source: tga.gov.au
RNA

Pfizer/BioNTech

Comirnaty Bivalent Original/Omicron BA.1

Approved in 35 countries
3 trials in 5 countries
Approval Source: tga.gov.au

29 in Clinical Trials in Australia

Protein Subunit

Clover

SCB-2019

15 trials in 13 countries
Protein Subunit

Novavax

Nuvaxovid

Approved in 40 countries
22 trials in 14 countries
Protein Subunit

Sanofi/GSK

Recombinant Protein

6 trials in 7 countries
Protein Subunit

Vaxine/CinnaGen Co.

SpikoGen

Approved in 1 country
8 trials in 2 countries
RNA

Moderna

Spikevax

Approved in 88 countries
70 trials in 24 countries
RNA

Pfizer/BioNTech

Comirnaty

Approved in 149 countries
100 trials in 31 countries
Protein Subunit

Icosavax

IVX-411

2 trials in 1 country
Protein Subunit

Novavax

ICC Vaccine

3 trials in 2 countries
Protein Subunit

Novavax

SII B.1.351

2 trials in 1 country
Protein Subunit

Novavax

SII B.1.617.2

2 trials in 1 country
Protein Subunit

Novavax

SII Bivalent

2 trials in 1 country
VLP

SpyBiotech

RBD SARS-CoV-2 HBsAg VLP

2 trials in 1 country
Protein Subunit

University of Melbourne

DoCo-Pro-RBD-1

DNA

Symvivo

bacTRL-Spike

DNA

University of Sydney

COVIGEN

RNA

University of Melbourne

MIPSCo-mRNA-RBD-1

Non Replicating Viral Vector

EnGeneIC

COVID-19-EDV

Non Replicating Viral Vector

Tetherex Pharmaceuticals Corporation

SC-Ad6-1

RNA

EyeGene Inc

EG-COVID-003

2 trials in 1 country
Protein Subunit

Novavax

Bivalent SARS-CoV-2 rS Vaccine

Protein Subunit

Novavax

NVX-CoV2515

RNA

Moderna

Spikevax Bivalent Original/Omicron BA.1

Approved in 38 countries
5 trials in 4 countries
RNA

Pfizer/BioNTech

Comirnaty Bivalent Original/Omicron BA.1

Approved in 35 countries
3 trials in 5 countries
Protein Subunit

ACM Biolabs

ACM-001

RNA

GlaxoSmithKline

CV0501

RNA

RVAC Medicines

RVM-V001

RNA

Moderna

mRNA-1230

RNA

Chulalongkorn University

ChulaCov19

5 trials in 2 countries
Protein Subunit

Intravacc B.V.

Avacc 10

2 Vaccines with Trials in Australia are No Longer Progressing

Protein Subunit

Queensland

Sclamp

Protein Subunit

Icosavax

IVX-411

2 trials in 1 country